{"id":"W2037157828","doi":"10.1016/j.clbc.2013.08.011","title":"Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Exemestane; Medicine; Everolimus; Breast cancer; Oncology; Internal medicine; Hormone receptor; Aromatase; Cancer; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001554842,0.0004983817,0.001818113,0.0003243827,0.0002397042,0.0007979677,0.0004882879,0.0006577671,0.002200675],"category_scores_gemma":[0.001533663,0.0003190138,0.001534429,0.0003450712,0.0004307371,0.0007253655,0.0004437484,0.00153675,0.0003462535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007980281,"about_ca_system_score_gemma":0.0008219046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004366038,"about_ca_topic_score_gemma":0.001508225,"domain_scores_codex":[0.9996005,0.0001773496,0.00004626786,0.00007514757,0.00004701794,0.00005380501],"domain_scores_gemma":[0.9992817,0.0001454101,0.0002556929,0.00003664761,0.00002807475,0.0002524505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9318219,0.004975503,0.01238746,0.0006041335,0.0017351,0.0001150855,0.00008391479,0.0008073614,0.006543196,0.00007245078,0.0007957037,0.04005833],"study_design_scores_gemma":[0.6227151,0.2846884,0.0817662,0.0002279487,0.003479984,0.0003925357,0.00009028526,0.001182222,0.002091313,0.0001881649,0.003130436,0.00004738721],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885858,0.009256128,0.00009070196,0.0002423679,0.00007893109,0.0002256598,0.0004501313,0.00001575394,0.001054564],"genre_scores_gemma":[0.9935725,0.003192728,0.0003541521,0.0005838145,0.00015515,0.0003004583,0.001063398,0.000006572522,0.0007713348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002200675,"threshold_uncertainty_score":0.008222938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009278835326357648,"score_gpt":0.2903044741973232,"score_spread":0.2810256388709656,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}